Ceramics-based technologies on show at MD&M West

Kyocera will be highlighting its ceramics-based technologies at MD&M West. With its 60-year track record of providing custom engineering solutions, Kyocera aims to use its unique ceramic materials to help advance the latest medical technologies. 

Kyocera’s ceramics aim to provide a durable, long-lasting, non-reactive material to help improve everything from medical tweezers and needles to hip implants. Innovative ceramic medical solutions will be on display including Kyocera’s alumina-sapphire direct bonding microchemical chip.

The new decade is bringing a radical transformation of healthcare based on Information and Communication Technology (ICT), particularly in developing regions. One example is the challenge to develop an affordable, reliable device that can quickly diagnose HIV, tuberculosis, malaria and other diseases, based on samples of blood, saliva and/or sputum, for use by rural clinics that may have electricity only a few hours per day. Kyocera’s proprietary Alumina-Sapphire microchemical chip is inspired in part by this challenge.

It is designed for use in blood, saliva and sputum analysis; clinical tests; genome analysis and other diagnostic solutions. Since its direct bonding technology requires no separate bonding material, Kyocera’s solution aims to enable a stronger connection; higher heat resistance; superior chemical resistance; and greatly reduced risk of error from substance or particle contamination. 

In many other examples, Kyocera’s Fine Ceramics can be found in solutions for genetic sequencing, blood separators, X-ray machines, pacemakers, cardiac monitors, neuromodulation devices, surgical tools, drug testing and orthopaedic joint replacement systems. Many of these products will be on display at Kyocera’s MD&M West booth, showcasing technologies from metallised ceramics for implantable devices, to zirconia hypodermic needles featuring an astounding internal-diameter dimensional precision plus-or-minus a single micron.

MD&M West runs from 11-13 February at Anaheim Convention Center, California.